Stockreport

Cantor Fitzgerald Reaffirms Overweight Rating on Summit Therapeutics (SMMT) Before Key 2026 Catalyst [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF Summit Therapeutics Inc. (NASDAQ:SMMT) on December 19, citing a strong outlook for the company. Summit's upcoming global phase 3 HARMONi-3 study, which will evaluate ivo [Read more]